33 results
Mechanisms of Drug-Induced Hyperkalemia 
 • Direct renin inhibitor (Aliskiren)
 • Renin release inhibition (NSAIDs, Beta-Blockers)
• Direct renin inhibitor ... ) inhibitors (Lisinopril ... differential #diagnosis #pathophysiology ... #pharmacology # ... potassium #medications
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #Antidiabetic #Medications ... DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology ... #Pharmacology #
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... events TZDs DPP-4 inhibitors ... SGLT2 inhibitors ... comparison #management #endocrinology ... #dm2
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... Glycemic #Diabetes #DM2 ... #Control #Medication ... #Algorithm #Endocrinology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology ... heart disease • All ... #Pharmacology # ... Summary #DM2 #diabetes ... #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
different than other medications ... very tolerable medication ... Renal #Dosing #Pharmacology ... Management #Diabetes #DM2 ... #Endocrinology
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
After non-pharmacologic ... Remember that all ... is the newest medication ... commercial for this medication ... #Pharmacology #
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Common Diabetes Medications ... #Diabetes #Medications ... #pharmacology # ... pathophysiology ... #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... α-glucosidase inhibitor ... Diabetes #Mellitus #DM2 ... #pharmacology # ... comparison #table #endocrinology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... anti-diabetic medications ... #Pharmacology # ... Medications #DM2 ... #Diabetes #Endocrinology